Morgan Crucible/£MGAM

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Morgan Crucible

Morgan Advanced Materials plc, operating under the ticker MGAM, is a UK-based company renowned for its production of advanced carbon and ceramic materials. The company specializes in engineering high-performance materials utilized in various industrial sectors, including healthcare, electronics, and transportation. Founded in 1856, Morgan Advanced Materials has expanded its influence globally, focusing on delivering tailored solutions that address specific material challenges faced by their diverse client base.

Ticker

£MGAM

Primary listing

LSE

Employees

8,479

Morgan Crucible Metrics

BasicAdvanced
£615M
22.49
£0.10
1.07
£0.12
5.53%

What the Analysts think about Morgan Crucible

Analyst ratings (Buy, Hold, Sell) for Morgan Crucible stock.

Bulls say / Bears say

Morgan’s simplification programme is on track to achieve £22 million in annualised savings by 2025 (up from £10 million) at an exceptional cost of £45 million, demonstrating strong operational efficiency and self-help measures (Morningstar).
Sales in Q1 2025 declined just 3.5% organically, in line with guidance, and the company expects minimal tariff impact due to its predominantly localised manufacturing footprint, highlighting resilience in a challenging environment (Alliance News).
The board has launched a £40 million share buy-back programme, underscoring management’s confidence in the balance sheet and commitment to returning capital to shareholders amid near-term market weakness (DirectorsTalk Interviews)
Adjusted revenue for H1 2025 fell 8.7% year-over-year to £522.6 million, with an organic constant-currency decline of 5.8% and adjusted operating profit down 18.7%, compressing margins by 140 basis points to 11.1% (Nasdaq).
Shares plunged as much as 25% after Morgan warned that full-year adjusted operating profit would be at the lower end of consensus (£115.6 million–£126.3 million) and that no second-half recovery is expected, underscoring deep end-market uncertainty (Reuters via TradingView).
Citigroup cut its price target on MGAM stock from 265 pence to 240 pence despite maintaining a Buy rating, reflecting analyst concerns over limited upside and persistent demand headwinds (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.

Morgan Crucible Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Morgan Crucible Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £MGAM

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

FAQs